What is Gilbert Technologies?
Gilbert Technologies, a Dutch firm, is dedicated to advancing healthcare through the design and development of innovative and sustainable medical devices. The company specializes in novel inhalation devices engineered for superior lung deposition, targeting a range of pulmonary conditions including Cystic Fibrosis, Asthma, Oncology, and Pulmonary Arterial Hypertension, among others. Their disruptive technology aims to enhance patient care and quality of life through more effective pulmonary medicine administration.
How much funding has Gilbert Technologies raised?
Gilbert Technologies has raised a total of $7.5M across 1 funding round:
Series A
$7.5M
Series A (2023): $7.5M with participation from The RVO
Key Investors in Gilbert Technologies
The RVO
The RVO, established in 2014 and based in The Hague, Netherlands, supports Dutch economic growth by fostering entrepreneurship in sustainability and international business. Their involvement suggests a strategic alignment with Dutch innovation and economic development initiatives.
What's next for Gilbert Technologies?
With a major enterprise-level funding context and a recent strategic investment, Gilbert Technologies is poised for significant scaling and market penetration. This capital infusion is expected to accelerate product development, expand manufacturing capabilities, and bolster market entry strategies for their advanced inhalation devices. The company's focus on sustainable health technologies and its leadership in pulmonary drug delivery position it for substantial growth in the competitive medical device landscape.
See full Gilbert Technologies company page
